Angela Seaton
Impact in
- Oncology top 10%
- Chemokine receptors and signaling
- Cytokine Signaling Pathways and Interactions
-
- Immunotherapy and Immune Responses
- Immune cells in cancer
Papers in
-
- Bioactive Compounds and Antitumor Agents 3
-
- Cancer, Lipids, and Metabolism 2
- NF-κB Signaling Pathways 2
- Co-authors
- David WaughPatrick G. JohnstonMalcolm F. G. StevensGeoffrey WellsCatherine WilsonP. ScullinRyan S. GallagherJoe M. O’Sullivan
- Journals
- British Journal of Cancer (2 papers)Journal of Medicinal Chemistry (2 papers)Molecular Cancer Research (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)
- Partner nations
- United KingdomAustraliaGermany
In The Last Decade
Angela Seaton
12 papers receiving 776 citations
Peers
Comparison fields: 5 of 91
- Oncology 288
- Immunology 215
- Cancer Research 141
- Organic Chemistry 201
- Toxicology 19
Countries citing papers authored by Angela Seaton
This map shows the geographic impact of Angela Seaton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angela Seaton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angela Seaton more than expected).
Fields of papers citing papers by Angela Seaton
This network shows the impact of papers produced by Angela Seaton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angela Seaton. The network helps show where Angela Seaton may publish in the future.
Co-authors
The 25 scholars most cited alongside Angela Seaton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 10 | |
| 2 | 2008 | 27 | |
| 3 | 2008 | 118 | |
| 4 | 2008 | 99 | |
| 5 | 2007 | 169 | |
| 6 | 2007 | 98 | |
| 7 | CXCR2/NF-kappaB/Bcl-2-survivin signalling pathway promotes resistance to oxaliplatin in metastatic prostate cancer cells | 2006 | 2 |
| 8 | 2006 | 1 | |
| 9 | 2003 | 39 | |
| 10 | 2003 | 92 | |
| 11 | 2000 | 48 | |
| 12 | 2000 | 96 | |
| 13 | 2000 | 2 |
About Angela Seaton
Angela Seaton is a scholar working on Toxicology, Cancer Research, Immunology, Organic Chemistry and Immunology and Allergy, having authored 13 papers that have together received 801 indexed citations. Recurring topics across this work include Synthesis and biological activity (4 papers), Chemokine receptors and signaling (4 papers), Bioactive Compounds and Antitumor Agents (3 papers), Cancer therapeutics and mechanisms (3 papers), Ubiquitin and proteasome pathways (2 papers), Cancer, Lipids, and Metabolism (2 papers), Prostate Cancer Treatment and Research (2 papers) and NF-κB Signaling Pathways (2 papers). The work is most often cited by research in Oncology (288 citations), Immunology (215 citations), Cancer Research (141 citations), Organic Chemistry (201 citations) and Toxicology (19 citations). Angela Seaton has collaborated with scholars based in United Kingdom, Australia and Germany. Frequent co-authors include David Waugh, Patrick G. Johnston, Malcolm F. G. Stevens, Geoffrey Wells, Catherine Wilson, P. Scullin, Ryan S. Gallagher, Joe M. O’Sullivan, Tracey D. Bradshaw and Andrew D. Westwell. Their work appears in journals such as British Journal of Cancer, Journal of Medicinal Chemistry, Molecular Cancer Research, Journal of Pharmacology and Experimental Therapeutics and Bioorganic & Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.